跳到主要內容
big screen image small screen image
Font Size
A
A
A
轉寄 轉寄
(Exclusive License) Technology Transfer Enterprise Selection Announcement - Ex vivo Cultured Corneal Endothelial Cell Therapy
Date of Announcement
2026-02-02

Date of Announcement:2026/02/02

1、Technology:Ex vivo Cultured Corneal Endothelial Cell Therapy

2、Inventor:Prof. I-Jong Wang /  Department of Medicine, National Taiwan University. 

3、Enterprise Eligibility:

(1)Industry Category:Biotechnology and Medicine.

(2)Required Technical Know-how:Cell Culture.

(3)Required Machinery and Equipment:Incubator、Laminar Flow Cabinet.

(4)Required Research or Technical Staff:Cell Culture.

(5)Other Requirements:Nope.

4、How to apply: Please go to the Center of Industral-Academic Cooperation of the Office of Research and Development to inquire about relevant information. 

5、Announcement period: 

From the announcement date to 2026/05/01, late applications will not be accepted. Those who send materials by mail shall use the postmark as evidence.  

6、Contact window: 

Intellectual Property & Licensing Manager:Alex Kao

TEL:+886-2-3366-9988 

Email:cmkao@ntu.edu.tw

7.  Please refer to the attachment for the technical disclosure information of this case, and download the documents required for the application from the link (https://ord.ntu.edu.tw/w/ordntu/ncarea_20072015094493882)

File download:
TechnologyTransferEnterpriseSelectionAnnouncement-ExvivoCulturedCornealEndothelialCellTherapy
File size: 53kb